Rutar F - Search Results

1

Predictors of patient radiation exposure during transcatheter aortic valve replacement.

Goldsweig AM, Kennedy KF, Kolte D, Abbott JD, Gordon PC, Sharaf BL, Sellke FW, Ehsan A, Sodha NR, Rutar F, Aronow HD. Goldsweig AM, et al. Among authors: rutar f. Catheter Cardiovasc Interv. 2018 Oct 1;92(4):768-774. doi: 10.1002/ccd.27452. Epub 2017 Dec 27. Catheter Cardiovasc Interv. 2018. PMID: 29280551

2

Direct and indirect measurement of patient radiation exposure during endovascular aortic aneurysm repair.

Weiss DJ, Pipinos II, Longo GM, Lynch TG, Rutar FJ, Johanning JM. Weiss DJ, et al. Among authors: rutar fj. Ann Vasc Surg. 2008 Nov;22(6):723-9. doi: 10.1016/j.avsg.2008.06.008. Ann Vasc Surg. 2008. PMID: 18992664

3

Patient Radiation Dosage During Lower Extremity Endovascular Intervention.

Goldsweig AM, Kennedy KF, Abbott JD, Jones WS, Velagapudi P, Rutar FJ, Curtis JC, Tsai TT, Aronow HD. Goldsweig AM, et al. Among authors: rutar fj. JACC Cardiovasc Interv. 2019 Mar 11;12(5):473-480. doi: 10.1016/j.jcin.2018.11.005. JACC Cardiovasc Interv. 2019. PMID: 30846087 Free article.

4

Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members.

Rutar FJ, Augustine SC, Colcher D, Siegel JA, Jacobson DA, Tempero MA, Dukat VJ, Hohenstein MA, Gobar LS, Vose JM. Rutar FJ, et al. J Nucl Med. 2001 Jun;42(6):907-15. J Nucl Med. 2001. PMID: 11390555 Free article.

5

Feasibility and safety of outpatient Bexxar therapy (tositumomab and iodine I 131 tositumomab) for non-Hodgkin's lymphoma based on radiation doses to family members.

Rutar FJ, Augustine SC, Kaminski MS, Wahl RL, Siegel JA, Colcher D. Rutar FJ, et al. Clin Lymphoma. 2001 Dec;2(3):164-72. doi: 10.3816/clm.2001.n.022. Clin Lymphoma. 2001. PMID: 11779293 Review.

6

Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice.

Augustine SC, Norenberg JP, Colcher DM, Vose JM, Gobar LS, Dukat VJ, Hohenstein MA, Rutar FJ, Jacobson DA, Tempero MA. Augustine SC, et al. Among authors: rutar fj. J Am Pharm Assoc (Wash). 2002 Jan-Feb;42(1):93-100. doi: 10.1331/108658002763538125. J Am Pharm Assoc (Wash). 2002. PMID: 11833524

7

Establishing an institutional model for the administration of tositumomab and iodine I 131 tositumomab.

Hohenstein MA, Augustine SC, Rutar F, Vose JM. Hohenstein MA, et al. Among authors: rutar f. Semin Oncol. 2003 Apr;30(2 Suppl 4):39-49. doi: 10.1053/sonc.2003.23801. Semin Oncol. 2003. PMID: 12728406

8

Determination and control of volatilized 131I released in the preparation of 131I tositumomab dosages for radioimmunotherapy.

Augustine SC, Colcher DM, Rutar FJ, Norenberg JP, Vang K. Augustine SC, et al. Among authors: rutar fj. J Am Pharm Assoc (2003). 2003 Sep-Oct;43(5):646-8. doi: 10.1331/154434503322452319. J Am Pharm Assoc (2003). 2003. PMID: 14626760 No abstract available.

9

Addressing a radiation safety sentinel event alert: one state's experience.

Temme JB, Lane T, Rutar F, McGowan A. Temme JB, et al. Among authors: rutar f. Radiol Manage. 2012 Nov-Dec;34(6):10-6; quiz 17-8. Radiol Manage. 2012. PMID: 23270117

10

Initial experience with an electron FLASH research extension (FLEX) for the Clinac system.

Oh K, Gallagher KJ, Hyun M, Schott D, Wisnoskie S, Lei Y, Hendley S, Wong J, Wang S, Graff B, Jenkins C, Rutar F, Ahmed M, McNeur J, Taylor J, Schmidt M, Senadheera L, Smith W, Umstadter D, Lele SM, Dai R, Jianghu James D, Yan Y, Su-Min Z. Oh K, et al. Among authors: rutar f. J Appl Clin Med Phys. 2024 Feb;25(2):e14159. doi: 10.1002/acm2.14159. Epub 2023 Sep 21. J Appl Clin Med Phys. 2024. PMID: 37735808 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page